In the TCGA and GTEx databases, we found that GPX3 mRNA expression was downregulated in various types of cancers (Figure 1A), including BRCA, COAD, LUAD, ovarian cancer (OV), kidney renal clear cell carcinoma (KIRC), and endometrial cancer (EC). This evidence concerns the gene GPX3 and ovarian carcinoma.